DPIIT recognised startup Government of India
Startup India
Prognostics In-Med Private Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.97 Cr
▼ 53% YoY
Net loss · FY 2024
₹14.84 Lakh
Net margin -3.7%
EBITDA · FY 2024
-₹6.41 Lakh
EBITDA margin -1.6%
Authorised capital
₹1.05 Cr
Registered with MCA
Paid-up capital
₹14.56 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Prognostics In-Med Private Limited
Data last updated:
Prognostics In-Med Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 10 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U72900PN2018PTC174234. Its GSTIN is 27AAJCP6235C1ZH (Maharashtra).
The company has an authorised share capital of ₹1.05 Cr and a paid-up capital of ₹14.56 Lakh. It is led by directors including Mukund Raghunath and Latha Chandrasekaran Poonamallee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 4 Golden Galaxy Survey No. 20/20/5/2 Someshwarwadi Baner Road Pashan, Pune, Maharashtra, India – 411008.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.97 Cr, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹14.84 Lakh (net margin -3.7%) and EBITDA of -₹6.41 Lakh (EBITDA margin -1.6%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years and 218% over five years.
The company is associated with 1 brand: InMed. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 8 deals on record (5 funding rounds, 2 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹21.96 Cr; the latest was in November 2020. Its 4 peer companies in the Healthcare industry (Diagnostics and Pathology Labs, Healthcare Equipment Retail and Distribution), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 2 smaller; the largest is Chandra Scans Private Limited with revenue of ₹3.99 Cr.
Prognostics In-Med Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0205040). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website in-medprognostics.com.
Company details
CIN U72900PN2018PTC174234
Registration Number 174234
Incorporation Date 10 January 2018
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0205040
Key People
Mukund Raghunath Director Latha Chandrasekaran Poonamallee Director Rajesh Kumar Purushottam Director Recognitions & Rankings of Prognostics In-Med
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0205040
Contact details
Prognostics In-Med Private Limited's registered office is in Pune, Maharashtra. Its website is in-medprognostics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 4 Golden Galaxy Survey No. 20/20/5/2 Someshwarwadi Baner Road Pashan, Pune, Maharashtra, India – 411008
- IndustryHealthcare, Diagnostic Centers & Pathology Labs, Medical Equipment Retail & Distribution
To see the full contact details of Prognostics In-Med Private Limited, buy the company report.
Comprehensive company report
Prognostics In-Med Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prognostics In-Med is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Prognostics In-Med Private Limited, buy the company report.
Financials of Prognostics In-Med Private Limited
FY 2025 filings availablePrognostics In-Med Private Limited reported revenue of ₹3.97 Cr (down 53% YoY) for FY 2024.
Revenue · FY 2024
₹3.97 Cr ▼ 53%
Net loss · FY 2024
₹14.84 Lakh margin -3.7%
EBITDA · FY 2024
-₹6.41 Lakh margin -1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 53%
3 years · compounded
▲ 80%
5 years · compounded
▲ 218%
EBITDA CAGR growth
1 year
▼ 116%
3 years · compounded
▲ 59%
5 years · compounded
▲ 44%
Revenue fell 53% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 218%. EBITDA fell 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.6% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prognostics In-Med Private Limited, buy the company report.
Board of directors of Prognostics In-Med Private Limited
Prognostics In-Med has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukund Raghunath Also directs: Aciesind Private Limited | Director | 11 Jan 2020 | 6 Years 9 Months | Current |
| Latha Chandrasekaran Poonamallee | Director | 10 Jan 2018 | 8 Years 9 Months | Current |
| Rajesh Kumar Purushottam Also directs: Transcend Discoveries Private Limited | Director | 10 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Prognostics In-Med Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs, Healthcare Equipment Retail and Distribution), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chandra Scans Private Limited | ₹3.99 Cr (FY 2025) | 6.0% | Allahabad, Uttar Pradesh, India | |||
| B. L. Medicare Private Limited | ₹3.98 Cr (FY 2025) | -1.0% | Agra, Uttar Pradesh, India | |||
| Prognostics In-Med Private Limitedthis company | ₹3.97 Cr (FY 2024) | -₹14.84 Lakh | -3.7% | -53.0% | Pune, Maharashtra, India | |
| Kollegal Scanning & Diagnostic Centre Private Limited | ₹3.95 Cr (FY 2025) | -3.0% | Chamarajanagar, Karnataka, India | |||
| Vista Pramodini Medicare Private Limited | ₹3.94 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Prognostics In-Med Private Limited, buy the company report.
Auditor
Prognostics In-Med Private Limited is audited by R G TANKSALE & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R G TANKSALE & CO | FY 2021 | 130204W |
Shareholding
The shareholding of Prognostics In-Med Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Prognostics In-Med Private Limited, buy the company report.
Deals & funding
Prognostics In-Med Private Limited has 8 deals on record (5 funding rounds, 2 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹21.96 Cr; the latest was in November 2020.
Total deals
8
Funding rounds
5
Secondary share transfers
2
Convertible or debt financing
1
Disclosed funding
₹21.96 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2020 | Funding round | ₹63.8 Lakh | Investors: 4 individuals |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2018 | Funding round | ₹20 Lakh | Investors: 4 individuals |
| Apr 2018 | Funding round | ₹10 Lakh | Investors: 2 individuals |
To see the full deal history of Prognostics In-Med Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Prognostics In-Med Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Court case (Spl.Sum.Suit) | Filed against the company by Xotentia Solutions LLP Through Chand Swaroop Khanna | Pending |
To see the full case history of Prognostics In-Med Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prognostics In-Med Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prognostics In-Med has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCP6235C1ZH | Maharashtra | Active | 26 Mar 2018 |
To see the full GST registrations and return filing status of Prognostics In-Med Private Limited, buy the company report.
Recent activity
Prognostics In-Med Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Mukund Raghunath ceased to be Additional Director on 31 Dec 2020.
AGM
Prognostics In-Med Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Prognostics In-Med Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Mukund Raghunath ceased to be Additional Director.
Appointed
Mukund Raghunath was appointed as Director.
Appointed
Latha Chandrasekaran Poonamallee was appointed as Director.
Appointed
Rajesh Kumar Purushottam was appointed as Director.
Incorporation
10 Jan 2018
Prognostics In-Med Private Limited was registered on 10 Jan 2018 with Roc Pune & aged 8 years 9 months as per MCA records.
News
Frequently asked questions
Prognostics In-Med is an active private limited company based in Pune, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 10 January 2018 (8+ years old) and is registered under CIN U72900PN2018PTC174234.
Prognostics In-Med has 3 current directors:
- Mukund Raghunath - Director
- Latha Chandrasekaran Poonamallee - Director
- Rajesh Kumar Purushottam - Director
The latest financial statements of Prognostics In-Med on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Prognostics In-Med is 27AAJCP6235C1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Prognostics In-Med is U72900PN2018PTC174234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prognostics In-Med has 1 court case on record: 1 filed against it. 1 is pending.
Prognostics In-Med was incorporated on 10 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Prognostics In-Med has 8 deals on record (5 funding rounds, 2 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹21.96 Cr; the latest was in November 2020.
The peers of Prognostics In-Med by revenue are Chandra Scans Private Limited, B. L. Medicare Private Limited, Kollegal Scanning & Diagnostic Centre Private Limited, Vista Pramodini Medicare Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs, Healthcare Equipment Retail and Distribution), with the same principal business activity (other hospital and medical care activities).
Mukund Raghunath ceased to be Additional Director on 31 Dec 2020. Mukund Raghunath was appointed as Director on 11 Jan 2020. Latha Chandrasekaran Poonamallee was appointed as Director on 10 Jan 2018. Prognostics In-Med has 4 board changes on record in total.
Yes, Prognostics In-Med is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).